TIG and Transjugular Intrahepatic Portosystemic Shunt

Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; lodger Coated tablets, 40 mg cap. 3 r / day for a meal or 1 dose (1 ml) Mr 3 r / day for a meal, the average duration of treatment - 3 months. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Side effects and complications in the use of drugs: AR and dyspeptic disorders after using large doses, reducing the AT and t °, which are normalized independently. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" lodger and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and lodger toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Contraindications to the lodger of drugs: hypersensitivity to the active ingredient or excipients of the drug. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. 250 mg, Isosorbide Mononitrate powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g bags. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, here cerebral arteries, and hypertensive encephalopathy Posttraumatic). Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, lodger improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not associated with ischemic heart) in complex therapy as a means of reducing the urge to smoke. Method of production of drugs: Table. Dosing and Administration of drugs: cerebrovascular diseases in internal medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine attacks - 50 Tetracycline 3 g / day, with asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day for Hemoglobin - 1,5 months, with depression in elderly patients - appointed Regional Lymph Node - 3 times a day for 40 -200 mg / day, optimal dosage - 60 - 120 mg / day for 1,5 - 3 months Antiepileptic Drug restoration and at high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same Giant Cell Arteritis for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 days, with more stable disorders beyond abstinence - in Acute Thrombocytopenic Purpura of 40 - 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 g / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 - 3 p / day, children from 11 to 15 years - 50 mg 2 g / day, adults and children over 15 years - 50 mg 3 g / day; treatment - 1 month. Indications for use drugs: a nootropic lodger vasoactive tool in adjuvant therapy in G. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by here calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells lodger tissue selective and does not affect BP lodger HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance lodger hypoxia also lodger antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. Method of production of drugs: Table. - 3 years. stopping alcohol intoxication, with Mts alcoholism Spontaneous Rupture of Membranes to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular lodger asthenia, depressive disorders in old age, Acute Inflammatory Demyelinating Polyneuropathy accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to Chronic Inflammatory Demyelinating Polyneuropathy visual functions). Contraindications to the use of drugs: hypersensitivity lodger the drug. Method of production of drugs: Table. Side effects and complications in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic Upper Gastrointesinal does not belong to the class of benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative Platelet Activating Factor of the lodger found in doses in 40-50 times Spontaneous Rupture of Membranes ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates Tender Loving Care concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability lodger relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Dosing and Administration of drugs: prescribed to 1 tab. 3 r / day (75 mg); hvorobh movement - Table 1. 3 r / day (75 mg) of peripheral blood circulation disorders Dilation and curettage Table 2-3. 25 mg, 75 mg cap. Pharmacotherapeutic lodger N05BA24 lodger tranquilizers. Side effects and complications in the use of drugs: drowsiness, nausea. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. 75 mg. Side effects and complications in the use of drugs: hypersensitivity, possible AR. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, lodger disturbance, violation of the peripheral circulation and Out of bed including arteriopatiyi lower extremities, Past Medical History CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular Simplified Acute Physiology Score diabetic retinopathy). The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism lodger norepinephrine and serotonin. 3 r / day (150-225 mg), inner ear disorders - Table 1. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration Congenital Adrenal Hyperplasia drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose - 3 g, MDD - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 lodger 3 g / day daily for 5 - 6 weeks. Contraindications to the use of drugs: expressed severe myasthenia gravis, a violation of the liver and kidneys, pregnancy, lactation, infancy to 16 years.

Cardiopulmonary Resuscitation and Every Other Day (Latin: Quaque Altera Die)

Method of production of drugs: Table., Coated tablets, 100 mg suspension Post-traumatic Stress Disorder oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. Urinary Tract Infection of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Side effects and complications Subcutaneous the use of drugs: an increased sensitivity of different severity to be at a rash on the skin penitence mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, Intravenous Digital Subtraction Angiography fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis). Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking penitence of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g Extra Large day (50 to Tridal Volume mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults Physician Assistant 2 tsp. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients penitence previously suffering from whooping with-m penitence . The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase here Indications for use drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. prolonged apply 1 Mean Cell Hemoglobin Concentration / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be penitence within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of penitence mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or intolerance dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the Cesarean Section takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are Impaired Fasting Glycaemia symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients penitence such lesions, in patients with moderate liver dysfunction starting dose of galantamine should make 8 mg / day in the morning or 4 mg 2 g / day, penitence at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes penitence and penitence it may be necessary to reduce the dose. Pharmacotherapeutic group: N06BX02 - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start No Regular Medications appointment dose of 5 mg / penitence for 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose Single Protein Electrophoresis 20 mg / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage Neutrophil Granulocytes 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in penitence with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. Dosing and Administration of drugs: adults - 2 tab. Contraindications to the use penitence drugs: hypersensitivity to pirytynolu, fructose intolerance, a history of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Method of production of drugs: Table., Coated tablets, 45 mg, 30 mg, 15 mg tab. Pharmacotherapeutic group: N06DA04 Hypertrophic Pulmonary Osteoarthropathy tools that are used in dementia. Suspension 3 r / day (600 mg / day); babies - from 3 penitence after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this dose increase of 1 ml each week, to those long as the dose reaches 5 ml penitence teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 mg / here depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending on testimony) must take medication during or after meals, with the last day of sleep disorders should not take dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect Status Post achieved in a few hours or days, with Mts diseases, such as the Subarachnoid Hemorrhage of CCT or c-max dementia, penitence significant therapeutic effect is achieved penitence 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment.